IGC Pharma, Inc. (IGC)
(Delayed Data from AMEX)
$0.47 USD
-0.01 (-1.35%)
Updated Jul 24, 2024 03:59 PM ET
After-Market: $0.45 -0.02 (-3.85%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
IGC Pharma, Inc. [IGC]
Reports for Purchase
Showing records 1 - 15 ( 15 total )
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
SMALL-CAP SQUAWK
Provider: JGR Capital Partners
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Enters into Joint Venture Agreement in Vertical Farming Technology
Provider: SEETHRUEQUITY, LLC
Analyst: TANDON A
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Hires New Executive to Drive Initiative into Medicinal and Legal Marijuana Industry
Provider: SEETHRUEQUITY, LLC
Analyst: TANDON A
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
We initiate coverage with a price target of $3.05 per share
Provider: SEETHRUEQUITY, LLC
Analyst: TANDON A
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Provider: Zacks Investment Research
Analyst: RALSTON S
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Provider: Zacks Investment Research
Analyst: RALSTON S
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Provider: Zacks Investment Research
Analyst: RALSTON S
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
ValuEngine Detailed Valuation Report for IGC
Provider: VALUENGINE, INC
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
Initiating coverage with a Buy rating and a price target of $3.00.
Provider: REDCHIP
Analyst: KHANDEKAR A
Company: IGC Pharma, Inc.
Industry: Building Products - Heavy Construction
We are initiating coverage of IGC with a Buy rating and a price target of $3.00.
Provider: REDCHIP
|